News
Cipla launches the world’s first generic Pirfenidone in India
Cipla, among the world's leading generic pharmaceutical companies has introduced Pirfenidone in India; under the brand name Pirfenex, for the treatment of IPF. A chronic...
News
Sandoz announces launch of piperacillin and tazobactam for injection,...
Sandoz anounced the launch of piperacillin and tazobactam for injection, a generic equivalent of Zosyn®, in the US. Piperacillin and tazobactam for injection is an...
News
Bharat Biotech Announces Launched Indias First Cell-culture H1N1 Swine...
Bharat Biotech announced the launch of India?s first indigenously developed cell culture H1N1 swine fluvaccine under the brand name „HNVAC™. HNVAC™ is the only developing...
News
Sanofi-aventis Establishes Research Collaboration with Harvard University
Sanofi-aventis announced a research collaboration with Harvard University. The goal of the collaboration is to advance knowledge in the area of human health through basic...
News
FDA approved Dr. Reddy’s ANDA for Lansoprazole delayed-release capsules
Dr. Reddy’s Laboratories announced that it will be launching Lansoprazole delayed-release capsules (15 mg and 30 mg), a bioequivalent generic version of Prevacid®* Delayed-Release Capsules,...
News
First HIV diagnostic assay Results Available in Less Than...
Ortho Clinical Diagnostics announced U.S. FDA approval of a diagnostic assay for the detection of antibodies to human immunodeficiency virus (HIV) types 1+2 (Anti-HIV 1+2)...
News
Cephalon Announces FDA Approval of a Risk Evaluation and...
Cephalon, Inc.announced that a Risk Evaluation and Mitigation Strategy (REMS) for its antiepileptic medication GABITRIL(R) (tiagabine hydrochloride) has been approved by the U.S. Food and...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.